IMF TV

From our weekly series “Ask Dr. Durie” to comprehensive news from key cancer medical conferences around the world, IMF-TV is your all-access ticket to critical myeloma research, patient education and guidance. Check back often for regularly updated content. 

Dec
05
How do multiple myeloma experts define cure?
In this week’s video, Dr. Brian G.M. Durie explains the two definitions for cure in multiple myeloma – functional cure and true cure. BOTTOM LINE: ​ We are still unable to define cure, but the good(...)
Dec
03
IMWG Conference Series: 60th ASH Meeting
Patients, caregivers, and doctors around the world can view the IMF's popular livestream IMWG Conference Series, "Making Sense of Treatment" from the 2018 ASH Meeting at 8:30pm PT/10:00pm CT/11:00pm(...)
Dec
03
Top Multiple Myeloma Research Presented at ASH 2018
Dr. Joseph Mikhael presents an overview of the top multiple myeloma research presented at ASH 2018.
Dec
02
ASH 2018: Top Multiple Myeloma Research
Dr. Luciano Costa presents an overview of the top multiple myeloma research at ASH 2018.
Dec
02
Standardization of 18F-FDG PET/CT According to Deauville Criteria for MRD Evaluation in MM Patients
FDG PET/CT was confirmed to be a reliable predictor of outcomes in newly diagnosed MM, regardless of treatment. Reduction of FDG uptake lower than the liver after therapy, both in the FLs and in the(...)
Dec
02
Preliminary Outcome from the Open Label Phase II ALLGMM018/AMN003 Study
Carfilzomib lenalidomide and dexamethasone (KRd) is FDA-approved for the treatment relapsed/refractory multiple myeloma (RRMM) based on data from the ASPIRE study (Stewart K et al. NEJM 2015).(...)